Dana Farber Cancer Institute/Massachusetts General Hospital

Boston, Massachusetts 02115

We've found

3 trials

at this facility

STRIDE Biorepository

Status: Enrolling, Phase
Updated: 12/31/1969

from

Boston, MA

Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Boston, MA

Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

Status: Enrolling, Phase II
Updated: 4/30/2018

from

Boston, MA

Use our guide to learn which trials are right for you!